H epatitis C virus (HCV) is responsible for the vast majority of cases of transfusion-associated and community-acquired non-A, non-B hepatitis 1,2 and infects an estimated 170 million people worldwide. 3 The seroprevalence of anti-HCV antibody in the United States has been estimated at 1.8%, which corresponds to approximately 4 million people. 4 HCV is the leading cause of chronic viral hepatitis in the United States, 5 and HCV-infected individuals are the major recipients of liver transplantation. HCV, first molecularly cloned in 1989, 1 is a positive-strand RNA virus of the flavivirus family with a genome size of ϳ10 kb, which encodes a number of structural (core, E1, E2, and p7) and nonstructural (NS2, NS3, NS4A, NS4B, NS5A and NS5B) proteins. 6 HCV has at least 6 distinct but related genotypes with more than 50 subtypes, and genotype 1 is the most common in the United States, Europe, and most parts of Asia. HCV typically escapes clearance by the host's immune system and leads to the establishment of a persistent infection in approximately 70% of infected individuals. 7 The consequences of a subset of patients with chronic HCV infection are cirrhosis, liver failure, and hepatocellular carcinoma. 8, 9 Treatment of HCV with interferon alfa (IFN-␣) and ribavirin is associated with a sustained response rate of less than 50%. 7,10,11 These limited therapeutic efficacies and the absence of an effective HCV vaccine underscore the importance of research on factors that enhance HCV infection and compromise IFN-␣-based therapy.
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Alcohol is the most commonly used and abused drug in the United States. Alcohol abuse significantly affects morbidity and mortality from infectious diseases. 12 Alcohol consumption accelerates liver damage, diminishes therapeutic response to IFN-␣, and increases the rate of hepatocellular carcinoma in patients with chronic HCV infection. [13] [14] [15] [16] [17] [18] Alcohol added in vivo and in vitro also impairs liver parenchymal cells and various functions of immune cells, including monocytes, T cells, and natural killer cells, which contribute to hepatocyte damage in chronic HCV infection. 12, 19 Alcohol consumption and viral hepatitis infection, both recognized as major causes of liver disease worldwide, frequently coexist in patients with chronic liver disease. 13, 17, 18 Alcohol and HCV most likely act synergistically to promote the development and progression of liver damage. 17, 18 There is little direct information available concerning the effects of alcohol abuse on HCV replication in hepatic cells. This lack of knowledge about the impact of alcohol abuse on HCV is a major barrier to fundamental understanding of HCVrelated morbidity and mortality in alcohol abusers with HCV infection. Thus, it is critical to investigate the impact of alcohol abuse on HCV replication in the target cells such as hepatic cells. We investigated whether alcohol enhances HCV RNA expression in HCV replicon containing cell lines. 20, 21 We also studied whether the in vitro addition of alcohol to these cells compromises the anti-HCV effect of IFN-␣. 21 The replicon in Huh.8 cells contains both the 5Ј nontranslating region and 3Ј nontranslating region as well as the open reading frame of the nonstructural proteins NS3-5B. 21 Southern blots are negative for replicon nucleic acid integrated into the host chromosome in Huh.8 cells. 21 Using a real-time reverse-transcription polymerase chain reaction (RT-PCR) assay that we have recently developed, 22 we were able to detect ϳ2,500 to 5,000 copies of HCV messenger RNA (mRNA) per Huh.8 cell. Huh.2 is a cell clone containing a G418 selectable HCV replicon with HCV NS5A mutation (S1172P). 21 FCA-1 cells contain a subgenomic replicon from a known infectious HCV clone with several consensus mutations in NS3 as well as in NS5A (NS3: E177G; NS5A: D1229E, I1299V). 20 The HCV replicon containing cells and Huh7 cells were maintained in Dulbecco Modified Eagle's Medium (Gibco-BRL, Grand Island, NY) supplemented with 10% (vol/vol) fetal bovine serum (HyClone, Logan, UT), 100 U/mL penicillin, 100 g/mL streptomycin, 2 mmol/L L-glutamine, and 0.1 mmol/L minimum essential medium nonessential amino acids in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. The culture medium for Huh.8, Huh.2, and FCA-1 cells contained G418 (750 g/mL). Cells were passaged every 2 or 3 days and seeded in 24-well plates at a density of 10 5 cells/well.
Materials and Methods

Reagents
Alcohol Treatment. The HCV replicon containing cells (Huh.8, Huh.2, and FCA-1) and Huh7 cells plated in 24-well plates were incubated with or without alcohol (ϳ10 to 100 mmol/L) for up to 96 hours. For multiple time-point treatment, the cells were treated with alcohol daily. To study whether alcohol interferes with the anti-HCV effect of IFN-␣, Huh.8 cells were incubated with alcohol (100 mmol/L) and/or IFN-␣ (100 U/mL). IFN-␣ was added to the cell cultures for 30 minutes before the addition of alcohol. We selected IFN-␣ at the concentration that was tested to have an anti-HCV effect in HCV replicon containing cells. 20, 21 In the experiments to investigate whether CAPE, a specific inhibitor of the activation of nuclear factor B (NF-B), suppresses the enhancing effect of alcohol on HCV RNA expression, Huh.8 cells were incubated with CAPE for 30 minutes before the addition of alcohol. The selected concentration of CAPE (20 g/mL) was based on our pilot experiments, which showed that CAPE at the concentrations of 20 to 30 g/mL resulted in a maximum inhibitory effect on HCV RNA expression without cytotoxic effect (trypan blue dye staining) on Huh.8 cells (data not shown). In addition, our pilot experiments showed that there was no cytotoxic effect of alcohol at the concentrations of 100 mmol/L 23 or less on the HCV replicon containing cells as shown by trypan blue dye staining. In some experiments, Huh.8 cells were preincubated with either 4-MP (0.1 mol/L) or cyanamide (0.2 mol/L) or naltrexone (10 Ϫ8 mol/L) for 30 minutes before the addition of alcohol.
To minimize alcohol evaporation that diminishes alcohol concentration in the plates, we maintained alcoholtreated cells in the plates sealed with PARAFILM (American National Can, Greenwich, CT). Furthermore, to avoid evaporated alcohol contamination of control culture plates, alcohol-treated and control plates were maintained in separate incubators.
RNA Extraction. Total RNA (1 g) was extracted from HCV replicon containing cells as well as from Huh7 cells using Tri-Reagent (Molecular Research Center, Cincinnati, OH). In brief, total RNA was extracted by a single-step guanidinium thiocyanate-phenol-chloroform extraction. After centrifugation at 13,000g for 15 minutes, the RNA-containing aqueous phase was precipitated in same volume isopropanol. RNA precipitates were then washed once in 75% alcohol and resuspended in 20 L of RNase-free water.
Real-Time RT-PCR for HCV RNA Quantification. We used the real-time RT-PCR assay newly developed in our laboratory for the quantification of HCV RNA. 22 The real-time PCR was performed with 1/10th of cDNA derived from RNA (1 g) extracted from the cells using ABI Prism 7700 Sequence Detection System (Applied Biosystems, Foster City, CA). We designed the primer pair (S130/AS311) that is specific for the recognition of highly conservative 5Ј-noncoding region (5Ј-NCR) in the HCV genome. 22 Their sequences are as follows: 5Ј-CGGGAG-AGCCATAGTGGTCTGCG-3Ј (S130) and 5Ј-CTC-GAAGCACCCTATCAGGCAGTA-3Ј (AS311). The probe (molecular beacon [MB]) sequence for HCV 5Ј-NCR was selected within the primer pair of S130 and AS311, which was designed to be perfectly complementary to the target sequence in 5Ј-NCR of HCV genome. 22 The following is the sequence of the MB: 5Ј-FAM-GCGAGCCAC-CGGAATTGCCAGGACGACCGCTCGC-DABCYL-3Ј. The stem sequence (underlined) of MB does not complement the sequences within the loop region. The MB was labeled at the 5Ј end with 6-carboxyfluorescein (6-FAM) and the quencher 4-(4Ј-dimethylaminophenylaso) benzoic acid (DABCYL) at the 3Ј end. Both primers and MB were suspended in Tris-EDTA buffer and stored at Ϫ30°C. Thermal cycling conditions were designed as follows: initial denaturation at 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 60 seconds. Fluorescence measurements were recorded during each annealing step. At the termination of each PCR run, the data were automatically analyzed by the system and amplification plots were generated. For each PCR reaction, 2 L of cDNA template was added to 48 L of PCR master mixture (5 L of 1ϫ PCR buffer II, 5 mmol/L MgCl 2 , 300 nmol/L dNTP, 400 nmol/L of each primer, 1.5 U of AmpliTaq Gold DNA polymerase, 400 nmol/L of MBs, and 24.7 L of water).
The PCR buffer contained 5-carboxy-X-rhodamine (500 nmol/L) as the reference dye for normalization of the reactions. Any possible fluctuations in 5-carboxy-X-rhodamine signal are used to correct the sample signal. All amplification reactions were performed in duplicate. A standard curve was generated with 10-fold dilutions of HCV 5Ј-NCR RNA control 22 prequantitated by a spectrophotometer (Eppendorf Scientific, Inc., Westbury, NY).
Immunoblot Assay. Total cell lysates were prepared from Huh.8 cells (10 5 cells per well in a 24-well plate) incubated with or without alcohol for 72 hours using a lysis buffer (Promega, Madison, WI). The protein concentration was determined by DC protein assay kit (BioRad, Hercules, CA). The immunoblot analysis of HCV NS5 protein was performed using a Bio-Dot SF apparatus as described by the manufacturer. Briefly, total protein (0.5 g) extracted from Huh.8 cells incubated with or without alcohol (100 mmol/L) was applied onto a nitrocellulose membrane. After the blockage with phosphate buffered saline containing 5% nonfat dry milk for 1 hour at room temperature, the membrane was incubated with a mouse monoclonal anti-HCV NS5 antibody at 4°C overnight. After washing 3 times with Tween phosphate-buffered saline, the nitrocellulose membrane was incubated with horseradish peroxidase-conjugated goat anti-mouse IgG for 1 hour. Bound antibody was visualized by developing the membrane in SuperSignal West Pico chemiluminescent substrate kit (Pierce, Rockford, IL). The results were recorded on film (Eastman Kodak, Rochester, NY).
NF-B Promoter Activation Assay. The plasmid (pNF-B-Luc) containing NF-B promoter linked with a luciferase gene was generated by Dr. Daniel Petrak. 24 Two copies of the mouse light chain enhancer 25 were cloned into pBLCAT3 vector, 26 and then the construct was modified by replacing the chloramphenicol acetyltransferase reporter with the luciferase gene obtained from pGEM-Luc. 24 Plasmid DNA was prepared by Miniprep techniques, according to the manufacturer's instructions (Wizard Plus Minipreps, Promega, Madison, MI) and used in transfection experiments. For transfection experiments, Huh.8 and Huh7 cells were seeded in a 6-well tissue culture plate at the density of 3 ϫ 10 5 cells per well 1 day before the transfection. The cells were transfected with the pNF-B-Luc using FuGENE 6 Transfection Reagent (Roche Diagnostic Corporation, Indianapolis, IN) with a ratio of FuGENE 6: plasmid 6:1 (L:g). Six hours after the transient transfection, the cells were incubated with or without alcohol (100 mmol/L) for 24 hours. At the termination of the experiments, the cells were harvested and washed twice with phosphate buffered saline by centrifugation at 3,300g for 3 minutes at room temperature. The cell pellets were lysed with 0.25 mL of 1ϫ Reporter Lysis Buffer (Promega) and a cycle of freezing and thawing in dry ice. Cell-free lysates were obtained by centrifugation at 10,000g for 30 seconds at room temperature. The effects of alcohol on the activation of NF-B promoter in these transiently transfected cells were determined by NF-B promoter-driven luciferase activity. Luciferase activity in cell lysate (50 L per sample) was quantitated using a Luciferase Assay System (Promega) and a luminometer. The results are presented as relative light units.
Statistical Analysis. All variables were tested in triplicate, and experiments were repeated at least 3 times. Triplicate wells had variability of less than 15%. One-way ANOVA was used to test for the difference in means and post-hoc t test was used for comparisons. The differences were considered significant if P Ͻ .05.
Results
Effect of Alcohol on HCV Replicon. To evaluate the effect of alcohol on HCV RNA expression in HCV replicon containing cells, we incubated Huh.8, Huh.2, and FCA-1 cells with or without alcohol. The alcohol concentrations selected for the study were based on our pilot experiments, which showed that alcohol at the concentration of 100 mmol/L or lower had no cytotoxic effect on Huh.8 cells (data not shown). Total cellular RNA extracted from the cell cultures was subjected to the realtime RT-PCR for the quantification of HCV RNA levels 72 hours after alcohol treatment. The addition of alcohol to Huh.8 cell cultures increased HCV RNA expression in a concentration-dependent fashion (Fig. 1A) . To determine whether the effect of alcohol on HCV RNA expression is time dependent, we incubated Huh.8 cells with alcohol (100 mmol/L) and harvested cells at 4 different time points (24 hours, 48 hours, 72 hours, and 96 hours) after alcohol treatment for HCV RNA quantification. The maximum HCV RNA expression in alcohol-treated Huh.8 cells was observed at 72 hours post-treatment (Fig.  1B) . Because NS5 protein plays a critical role in HCV replication, 21, 27 we also examined whether alcohol alters HCV NS5 protein expression in Huh.8 cells using the immunoblot assay. In comparison with untreated Huh.8 cells, alcohol (100 mmol/L)-treated cells express higher levels of NS5 protein as shown by the enhanced intensity of protein band (Fig. 2) . To determine whether the enhancing effect of alcohol on HCV replicon is not cell clone dependent, we examined the effect of alcohol on HCV replicon in 2 additional HCV replicon containing cell clones (Huh.2 and FCA-1). Similar to the findings observed in Huh.8 cells, alcohol increased HCV RNA expression in both Huh.2 and FCA-1 cells (Fig. 3) .
Alcohol Inhibits the Anti-HCV Effect of IFN-␣. Alcohol consumption impairs the therapeutic response to IFN-␣ in patients with HCV infection. [14] [15] [16] Because IFN-␣ inhibited HCV RNA expression in Huh.8 cells, 20, 21 we examined whether alcohol has a negative impact on the anti-HCV effect of IFN-␣ in HCV replicon containing cells. As expected, IFN-␣, when added to Huh.8 cell cultures, significantly inhibited HCV RNA expression (up to 90%) in Huh.8 cells (Fig. 4) . This anti-HCV effect of IFN-␣ on HCV, however, was attenuated by alcohol (Fig. 4) .
Alcohol Activates NF-B. To investigate the possible mechanism(s) responsible for alcohol-mediated upregulation of HCV RNA expression, we examined whether alcohol activates NF-B, an important transcriptional nuclear factor that controls viral replication and cytokine production. [28] [29] [30] Because HCV replicon expression in Huh.8 cells may activate NF-B, we transfected both Huh7 cells, the parental cell line of Huh.8, and Huh.8 cells with the plasmid (pNF-B-Luc) that contains NF-B promoter-linked to a luciferase gene. The transfected cells (24 hours post-transfection) were then incubated with or without alcohol. Alcohol enhanced the NF-B promoter-directed luciferase activity in both Huh7 and Huh.8 cells (Fig. 5A) . The basal levels of NF-B promoter-directed luciferase activity in Huh.8 cells are higher than those in Huh7 cells (Fig. 5A) . CAPE, a specific inhibitor of the activation of NF-B, abrogated alcohol-induced NF-B promoter activation (Fig. 5A ) in both Huh7 and Huh.8 cells. To further determine whether NF-B activation is directly involved in alcoholinduced HCV RNA expression, we examined whether CAPE abrogates the enhancing effect of alcohol in Huh.8 cells. CAPE, when added to Huh.8 cell cultures, completely blocked the enhancing effect of alcohol on HCV RNA expression (P Ͻ .01) (Fig. 5B) .
Naltrexone Abrogates Alcohol Action. Several lines of evidence indicate that alcohol interferes with the endogenous opioid system. [31] [32] [33] Morphine has the ability to promote HCV RNA expression in Huh.8 cells, which is blocked by naltrexone (Li Y, unpublished data). In addition, we have documented that both Huh7 and Huh.8 cells express -opioid receptor (Li Y, unpublished data). We therefore hypothesized that alcohol may activate the endogenous opioid system, which plays a role in alcoholinduced HCV RNA expression. To test this hypothesis, we first incubated Huh.8 cells with or without naltrexone (an opiate receptor antogonist) for 30 minutes before the addition of alcohol to the Huh.8 cell cultures. Naltrexone not only reversed the enhancing effect of alcohol on HCV RNA expression (Fig. 6A) , but also inhibited the alcoholinduced NF-B promoter activation (Fig. 6B) .
4-MP and Cyanamide Inhibit Alcohol-Induced HCV RNA Expression. To determine whether the enhancing effect of alcohol on HCV RNA expression in Huh.8 cells is specifically through the alcohol metabolite acetaldehyde, we examined whether 4-MP, an inhibitor of alcohol dehydrogenase, or cyanamide, an inhibitor of acetaldehyde dehydrogenase, blocks the enhancing effect of alcohol on HCV RNA expression in these cells. Pretreatment of Huh.8 cells with 4-MP or cyanamide attenuated the alcohol-induced increase of HCV RNA expression (Fig. 7) , whereas the addition of 4-MP or cyanamide alone to the cell cultures had little impact on HCV RNA expression (Fig. 7) .
Discussion
Alcohol abuse is a major cofactor in the development of HCV associated liver disease. [16] [17] [18] Chronic alcohol abuse mediates liver damage as a result of increase in production of proinflammatory cytokines. [34] [35] [36] [37] In the setting of chronic HCV infection, alcohol ingestion has an additional effect of diminishing immune clearance and increasing viral burden to hasten the onset of cirrhosis and hepatocellular carcinoma. 38 Serum HCV RNA levels were significantly higher in habitual alcohol drinkers with chronic HCV infection than in infrequent alcohol drinkers with chronic HCV. 39 HCV RNA levels were significantly higher in alcohol drinkers than abstainers, and the number of responders in IFN therapy decreased as alcohol intake increased. 40 These in vivo data strongly support the hypothesis that alcohol plays a role as a cofactor in promoting HCV RNA expression. To directly link the action of alcohol with HCV expression, we used recently developed HCV replicon containing cell lines for this study. The establishment of the subgenomic replicon system represents major progress in the molecular biology of HCV replication, 21, 27, 41 which provides the first effective cellular system available for the study of the dynamics of virus replication. Although the HCV replicon system Huh.8 cells (3 ϫ 10 5 cells/2 mL/well) plated in a 6-well plate were transfected with pNF-B-Luc for 24 hours and then incubated with or without alcohol (100 mmol/L) and/or naltrexone (10 Ϫ8 mol/L) for 24 hours. NF-B promoter-directed luciferase activity was normalized using the total protein of the cell-free lysates. The data are means Ϯ SD of triplicate cultures, and the experiment was repeated 3 times with similar results (**P Ͻ .01).
mimics only some aspects of HCV replication, this cell system provides an important means of investigating viral RNA and protein synthesis 21, 27, 41 and of characterizing those factor(s) that regulate HCV RNA expression. Using this system, we have for the first time shown that alcohol enhanced HCV replicon expression at both mRNA and protein levels (Figs. 1 through 3 ). This enhancing effect of alcohol is mediated specifically through its metabolite acetaldehyde, because 4-MP or cyanamide, the specific inhibitors of alcohol metabolism, blocks alcohol action on HCV RNA expression (Fig. 7) . These data indicate that Huh.8 cells are able to metabolize alcohol, probably through alcohol dehydrogenase, the main enzyme responsible for alcohol metabolism.
The underlying mechanisms of interaction between alcohol and HCV remain largely unknown. In the present study, we also investigated the possible mechanism(s) responsible for alcohol-mediated upregulation of HCV RNA expression. Because NF-B is a critical nuclear transcription factor involved in the activation of viral replication and cytokine production [28] [29] [30] and alcohol enhances NF-B activation in different cell systems, such as HepG2 cells, 42 we investigated whether alcohol, through the activation of NF-B, enhances HCV expression in Huh7 and Huh.8 cells. We showed that alcohol enhanced NF-B promoter-directed luciferase activity in both Huh7 and Huh.8 cells (Fig. 5A) . Because the basal levels of NF-B promoter-directed luciferase activity in Huh.8 cells are higher than those in Huh7 cells, it seems that HCV replicon expression in Huh.8 cells can activate NF-B. This finding is in agreement with a recent study showing that HCV NS5A alone or in the context of all the HCV nonstructural proteins is capable of inducing reactive oxygen species and activates NF-B. 43 Interestingly, alcohol also has the ability to induce oxidative stress, which has been shown to activate NF-B. 44 Thus, we hypothesized that the activation of NF-B is one of the mechanisms by which alcohol enhances HCV replication. We showed that CAPE, a specific inhibitor of the activation of NF-B, 45 blocked alcohol-induced NF-B promoter activation (Fig. 5A) , suggesting that the activation of NF-B may be involved in alcohol-mediated upregulation of HCV RNA expression. To confirm this speculation, we examined whether CAPE could block the enhancing effect of alcohol on HCV RNA expression. Our data showed that CAPE, when added to Huh.8 cell cultures, abolished the enhancing effect of alcohol on HCV RNA expression (Fig. 5B) . These data indicate that alcohol-mediated activation of NF-B is at least partially responsible for its action on HCV RNA expression.
Several lines of evidence indicate that alcohol interferes with the endogenous opioid system, [31] [32] [33] suggesting that the endogenous opioid system may be involved in alcohol action. The endogenous opioids play a key role in the rewarding (addictive) properties of alcohol. 46, 47 Pretreatment with opiate receptor antagonists (e.g., Naltrexone) decreases alcohol consumption in humans. 48, 49 Furthermore, treatment with naltrexone, an opiate antagonist, decreases ethanol consumption by alcoholic subjects. [47] [48] [49] [50] Opioid content, biosynthesis, and release are altered after alcohol treatment, although there is considerable disagreement regarding the direction of changes in the activity of the endogenous opioid system by alcohol. 46 We recently showed that Huh.8 cells express -opioid receptor and that morphine enhances HCV RNA expression in these cells (Li Y, unpublished data). Thus, we hypothesize that alcohol may activate the endogenous opioid system, through which it induces HCV RNA expression. We showed that naltrexone, an opiate receptor antagonist, not only blocked the promoting effect of alcohol on HCV RNA expression in Huh.8 cells (Fig. 6A) , but also diminished the enhancing effect of alcohol on NF-B promoter activation in these cells (Fig. 6B) . These data strongly suggest that the activation of the endogenous opioid system is also implicated in alcohol-induced HCV RNA expression.
Clinical trials indicate a therapeutic benefit of IFN-␣ treatment in chronic HCV infection. 13, 18 Currently available combination therapy with IFN-␣ and ribavirin is, however, effective in less than 50% of treated subjects. 7, 10, 11 Although a history of alcohol abuse is not a contraindication to clinical therapy, continued alcohol use during therapy adversely affects response to HCV treatment. Heavy alcohol consumption reduces the efficacy of IFN-␣ therapy for chronic HCV infection, 14 and this adverse effect of alcohol drinking on efficacy might be reversed, partly, by abstinence for a long period before treatments. Thus, it is important to identify whether alcohol is one of the cofactors that are responsible for the failure of IFN-␣ treatment. The HCV replicon system has been successfully used to examine the anti-HCV effect of IFN-␣. 20, 21 IFN-␣ inhibits HCV RNA expression in Huh.8 cells, as shown by a declined HCV RNA expression over time. 21 Our data (Fig. 4) showing that IFN-␣ significantly inhibited (up to 90%) HCV RNA expression in Huh.8 cells further confirms this observation. Thus, the Huh.8 cell line is an excellent in vitro model for studying whether alcohol interferes with the anti-HCV effect of IFN-␣ on HCV RNA expression. 21 We hypothesized that alcohol abuse may have a negative impact on the anti-HCV effect of IFN-␣. Our data support this hypothesis, showing that alcohol compromised the anti-HCV effect of IFN-␣ in Huh.8 cells (Fig. 4) . This finding suggests the possibility that alcohol may reduce efficacy of IFN-␣ therapy in vivo. The mechanism(s) responsible for the IFN-␣-mediated therapeutic effect remain unclear. 20 Thus, further studies are critical to determine the mechanism(s) responsible for the anti-HCV ability of IFN-␣ and whether alcohol has the ability to interfere with the mechanism(s) involved in IFN-␣ action against HCV.
In summary, our data show that alcohol has the ability to potentiate HCV replicon expression at both mRNA and protein levels. Also, alcohol compromises the anti-HCV effect of IFN-␣ in HCV replicon containing hepatic cells. NF-B activation by alcohol may be, at least partially, responsible for alcohol-mediated upregulation of HCV RNA expression. In addition, alcohol-induced activation of the endogenous opioid system may be an additional mechanism by which alcohol induces HCV expression. These important observations in conjunction with the in vivo observations [13] [14] [15] [16] [17] [18] 40 are beneficial for further biological and immunological studies on cellular and molecular mechanism(s) involved in regulation of HCV replication in both in vitro and in vivo models. Our data also provide practical guidance toward the reduction of risk factors that interfere with IFN-␣-based therapy against HCV infection.
